⌘K

Home/Filings/4/0001209191-14-075134

4//SEC Filing

IDERA PHARMACEUTICALS, INC. 4

Accession 0001209191-14-075134

CIK 0000861838operating

View on SEC.gov Company Profile

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 8:15 PM ET

Size

5.5 KB

Accession

0001209191-14-075134

Insider Transaction Report

Form 4

Period: 2014-12-10

IDERA PHARMACEUTICALS, INC.IDRA

Arcudi III Louis J

Chief Financial Officer

Transactions

Award
Stock Option
2014-12-10+200,000→ 200,000 total
Exercise: $3.97Exp: 2024-12-10→ Common Stock (200,000 underlying)

Footnotes (1)

[F1]The option vests in equal quarterly installments over four years, with the first installment vesting on March 10, 2015.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IDERA PHARMACEUTICALS, INC.

CIK 0000861838

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000861838

Filing Metadata

Form type: 4
Filed: Dec 11, 7:00 PM ET
Accepted: Dec 12, 8:15 PM ET
Size: 5.5 KB

View on SEC.gov